ORBIMED ADVISORS LLC - 22 Apr 2025 SCHEDULE 13D/A Report for Passage BIO, Inc. Common Stock (PASG)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: Passage BIO, Inc. Common Stock
Symbol: PASG
Shares outstanding: 62.1M shares
Disclosed Ownership: 6.65M shares
Ownership: 10.7%
Form type: SCHEDULE 13D/A
Filing time: 25 Apr 2025, 19:48:26 UTC
Date of event: 22 Apr 2025
Previous filing: 26 Dec 2024
Next filing: 09 Jul 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	10.7%	6.65M	0	6.65M	/s/ Carl L. Gordon	Carl L. Gordon/Member	0001055951
ORBIMED CAPITAL GP VII LLC	10.7%	6.65M	0	6.65M	/s/ Carl L. Gordon	Carl L. Gordon/Member of OrbiMed Advisors LLC	0001760648